Cargando…
Autoimmune Rheumatic Disease Flares with Myocarditis Following COVID-19 mRNA Vaccination: A Case-Based Review
Since the introduction of coronavirus disease 2019 (COVID-19) messenger ribonucleic acid (mRNA) vaccines, there have been multiple reports of post-vaccination myocarditis (mainly affecting young healthy males). We report on four patients with active autoimmune rheumatic diseases (ARDs) and probable...
Autores principales: | Lai, Yi Wye, Chua, Choon Guan, Lim, Xin Rong, Francis, Prabath Joseph, Xu, Chuanhui, Howe, Hwee Siew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609433/ https://www.ncbi.nlm.nih.gov/pubmed/36298637 http://dx.doi.org/10.3390/vaccines10101772 |
Ejemplares similares
-
Myocarditis and pericarditis following mRNA vaccination in autoimmune inflammatory rheumatic disease patients: A single‐center experience
por: Patel, Shreeya, et al.
Publicado: (2022) -
Post-mRNA vaccine flares in autoimmune inflammatory rheumatic diseases: Results from the COronavirus National Vaccine registry for ImmuNe diseases SINGapore (CONVIN-SING)
por: Ma, Margaret, et al.
Publicado: (2023) -
Autoimmune manifestations of CTLA-4 haploinsufficiency in two patients of Southeast Asian ethnicity
por: Lim, Xin Rong, et al.
Publicado: (2023) -
Efficacy and risk of mRNA vaccination in patients with autoimmune inflammatory rheumatic diseases
por: Kato, Yasuhiro, et al.
Publicado: (2023) -
Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine
por: Spinelli, Francesca Romana, et al.
Publicado: (2022)